Motif Bio Share Price - MTFB

0.00
-0.10501 (-100.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Motif Bio PLC MTFB NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.105011 0.00 0.00 0.00 0.105011 19:00:00
Bid Price Ask Price Spread Spread % News
0.105 0.109 0.004 3.67% - -
Last Trade Time Type Quantity Stock Price Currency
- 0  0.00 USD

Motif Bio Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
 2.55M 24.27M  -13.99M -1.40 - 24.27M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News Motif Bio

Loading Messages....

Latest MTFB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

MTFB Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Motif Bio PLC is a UK-based biopharmaceutical company. Its business is to develop antibiotics for the treatment of infections caused by multi-drug resistant bacteria. The company's key product is the Iclaprim, which addresses bacterial infections, such as acute bacterial skin and skin structure infections and hospital-acquired bacterial pneumonia. Iclaprim exhibits potent activity against Gram-positive clinical isolates of various genera of staphylococci. Motif Bio generates revenue from the sale of its pharmaceutical products mainly in the United Kingdom.


Your Recent History
NASDAQ
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.